fbpx
loading
Results from a phase III trial Proton Therapy in Head and Neck Cancer

A groundbreaking multi-institution Phase III trial led by The University of Texas MD Anderson Cancer Center reveals that intensity modulated proton therapy (IMPT) provides significant benefits for patients with oropharyngeal cancer. Compared to traditional intensity modulated radiation therapy (IMRT), IMPT showed similar progression-free survival rates but significantly reduced malnutrition and feeding-tube dependence. With a median […]

Data privacy

The protection of your personal data is important to us, and we aim to comply with the requirements ofthe Personal Data Protection Act 2012 (“PDPA”) in respect of the collection, use and disclosure of your personaldata. Please read the our Data Protection Notice for information on how we manage your personal data. If you have any enquiries regarding the our […]

Skull base tumour webinar on proton therapy
Skull base tumour webinar

RO-SE will be conducting a webinar on skull base tumours and their management with endoscopic surgery and proton therapy on April 12th, 2024, 8AM.

3D versus VMAT
Esophageal cancer

Esophageal cancer can be broadly classified into two main types based on the type of cells from which the cancer originates: squamous cell carcinoma and adenocarcinoma. Each type has different risk factors, locations within the esophagus, and treatment approaches. The treatment of esophageal cancer can be in several forms. Treatment plans are often determined through […]

Radiotherapy for pediatric cancers

Radiotherapy is a medical treatment that uses high doses of radiation to kill or damage cancer cells. It is a common part of the treatment plan for many types of cancers, including pediatric tumors. The goal of radiotherapy is to target and destroy cancer cells while minimizing damage to surrounding healthy tissues. As childhood cancers […]

nasopnaryngeal carcinoma radiotherapy dose
Twice daily radiotherapy for recurrent nasopharyngeal carcinoma

Nasopharyngeal carcinomas are most prevalent in South East Asia. Up to 10 to 20% of patients with nasopharyngeal carcinoma may experience a local relapse. Treatment options for recurrent nasopharyngealcarcinoma are dependent on a few factors. Time since first radiotherapy, extent of disease, and patient’s status etc. must be considered. Re-irradiation is one of these treatment […]

pexels terje sollie
Proton therapy for esophageal carcinoma

Dose comparison image credit to Oklahoma Proton Center. Esophageal cancer is a malignancy that arises in the esophagus, the tube that carries food from the mouth to the stomach. For early-staged esophageal cancers ( small tumours without nodal spread), surgery alone is sufficient. When tumours are bigger or have spread to lymph nodes, chemotherapy and/or […]

Skull base Chordoma
Skull base chordomas

Chordoma is a rare tumour which is thought to arise from remnants of the embryonic notochord (cartilage). Generally, it is slow-growing, although rarely, some chordomas can be more aggressive. It can grow anywhere along the spine column. Today we will discuss skull base chordomas specifically due to the complex treatment strategy required. Managing base of […]